Had a chance to see get a sneak peek of this back in April when I visited with the company in Israel.  ASI, a global leader in the development and sale of computer aided imaging solutions for cytogenetics, pathology and the life sciences...

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 -- Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1...

Carlsbad, CA – January 11, 2017 – Applied Spectral Imaging (ASI) announced today that its GenASIsTM  applications comply with CE-IVD requirements under the European Directive on In Vitro Diagnostic Medical Devices, for automated analysis...

Carlsbad, CA. – November 22, 2016 – Applied Spectral Imaging (ASI) announced today that they have entered into a collaboration with ARUP Laboratories to facilitate the development and commercialization of advanced digital pathology...

This is the fourth in a series of CEO short interviews about their views on their company, the digital pathology market, lessons learned and perhaps a little insight into their business principles.  My personal thanks to Ms. Shiposh and the...

Partnership is intended to overcome limitations of existing methods, widening the range of genetic abnormalities that can be screened.  Carlsbad CA, US and Sarcelles, FRANCE – November 4, 2015 – Applied Spectral Imaging (ASI,...